AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8300840 — intervention group
Group type: COMPARATOR
Intervention: Gemeprost vaginal pessary 1 mg (up to five doses)
Number of subjects: 60
Study 3488280 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy with biofeedback
Number of subjects: 12
Study 3488280 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 12
Study 29866947 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 29866947 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice (IC) of chemotherapy
Number of subjects: 0
Study 26428900 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Velocity (HV) exercise
Number of subjects: 38
Study 26428900 — intervention group
Group type: COMPARATOR
Intervention: Low-Velocity (LV) exercise
Number of subjects: 38
Study 24836125 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg daily)
Number of subjects: 885
Study 24836125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 885
Study 22733440 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabecular Metal Cone (TM Cone)
Number of subjects: 40
Study 22733440 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 40
Study 21029638 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone extended-release tablets
Number of subjects: 81
Study 21029638 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 81
Study 18230966 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg x day(-1)
Number of subjects: 15
Study 18230966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 15927974 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential pulmonary vein ablation
Number of subjects: 100
Study 15927974 — intervention group
Group type: COMPARATOR
Intervention: Segmental pulmonary vein ablation
Number of subjects: 100
Study 12915747 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine 100 mg per day
Number of subjects: 115
Study 12915747 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine (responders subgroup)
Number of subjects: 115
Study 12915747 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine
Number of subjects: 115
Study 12915747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 11295661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine, 0.25 mg/kg, twice daily for 18 months
Number of subjects: 817
Study 11295661 — intervention group
Group type: COMPARATOR
Intervention: Placebo, matching placebo twice daily for 18 months
Number of subjects: 817
Study 9260417 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment for dental hard tissue
Number of subjects: 0
Study 7684993 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (3 courses of the 'quick' VBP scheme)
Number of subjects: 151
Study 7684993 — intervention group
Group type: COMPARATOR
Intervention: Control group (no neoadjuvant chemotherapy)
Number of subjects: 151
Study 7684993 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 151
Study 3563121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 20
Study 3563121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29701042 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) at 2 Hz/100 Hz, 8 to 12 mA, applied at specific acupoints 30 min before anesthesia induction to the end of operation.
Number of subjects: 100
Study 29701042 — intervention group
Group type: COMPARATOR
Intervention: Control group with stimulation electrode applied at corresponding points without electrical stimulation.
Number of subjects: 100
Study 27316324 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime chronotherapy with ≥1 conventional hypertension medications
Number of subjects: 0
Study 25808497 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression method (80-160 mL balloon volume)
Number of subjects: 88
Study 25808497 — intervention group
Group type: COMPARATOR
Intervention: Standard method (50 mL balloon volume)
Number of subjects: 88
Study 23931043 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum magnesium concentration (1.60‐2.50 mmol/L)
Number of subjects: 162
Study 23931043 — intervention group
Group type: COMPARATOR
Intervention: Normal serum magnesium concentration (0.65‐1.05 mmol/L)
Number of subjects: 162
Study 20099160 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable Bifidobacterium supplement
Number of subjects: 60
Study 20099160 — intervention group
Group type: COMPARATOR
Intervention: Routine enteral nutrition alone (Control)
Number of subjects: 60
Study 18996860 — intervention group
Group type: EXPERIMENTAL
Intervention: All‐Bran (AB)
Number of subjects: 23
Study 18996860 — intervention group
Group type: EXPERIMENTAL
Intervention: Bran Buds with Corn (BBC)
Number of subjects: 23
Study 18996860 — intervention group
Group type: EXPERIMENTAL
Intervention: Bran Buds with Psyllium (BBP)
Number of subjects: 23
Study 18996860 — intervention group
Group type: EXPERIMENTAL
Intervention: BBC with viscous fiber blend (VFB)
Number of subjects: 23
Study 18996860 — intervention group
Group type: COMPARATOR
Intervention: Low‐fiber control
Number of subjects: 23
Study 16796496 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (experimental group, n = 10)
Number of subjects: 19
Study 16796496 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention (control group, n = 9)
Number of subjects: 19
Study 14983963 — intervention group
Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy
Number of subjects: 121
Study 14983963 — intervention group
Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy with serum PSA < 4 ng/mL
Number of subjects: 121
Study 14983963 — intervention group
Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy with serum PSA >= 4 ng/mL
Number of subjects: 121
Study 14983963 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative prediction model combining biopsy results and serum PSA levels
Number of subjects: 121
Study 10986023 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriography followed by carotid surgery (Group A)
Number of subjects: 186
Study 10986023 — intervention group
Group type: COMPARATOR
Intervention: Carotid surgery alone (Group B)
Number of subjects: 186
Study 8714328 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD assessment using Khmer translated version of the PTSD section of Diagnostic Interview Schedule for Children and Adolescents
Number of subjects: 99
Study 8714328 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression assessment using Khmer translated version of the depression section of the Schedule for Affective Disorders and Schizophrenia for School‐Age Children‐Epidemiologic Version and the Beck Depression Inventory
Number of subjects: 99
Study 8714328 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of Events Scale administered to assess trauma impact
Number of subjects: 99
Study 8714328 — intervention group
Group type: EXPERIMENTAL
Intervention: Full PTSD syndrome assessment
Number of subjects: 99
Study 29104028 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (iVR) surgical training using Oculus Rift and Leap Motion devices
Number of subjects: 95
Study 29104028 — intervention group
Group type: COMPARATOR
Intervention: Standard PowerPoint presentation on a laptop
Number of subjects: 95
Study 27191165 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone, 17 oral doses, supra-threshold concentrations (150 μM)
Number of subjects: 0
Study 27191165 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone, 17 oral doses
Number of subjects: 0
Study 25640621 — intervention group
Group type: EXPERIMENTAL
Intervention: Kavo PrepAssistant
Number of subjects: 76
Study 25640621 — intervention group
Group type: COMPARATOR
Intervention: Classical evaluation
Number of subjects: 76
Study 23254592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (200 mg twice daily for 8 weeks)
Number of subjects: 32
Study 23254592 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 32
Study 21364610 — intervention group
Group type: EXPERIMENTAL
Intervention: Hassawi rice (HR)
Number of subjects: 13
Study 21364610 — intervention group
Group type: COMPARATOR
Intervention: Uncle Ben's rice (UBR)
Number of subjects: 13
Study 18821287 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone phenpropionate (100 mg, intramuscularly, pulse-dose)
Number of subjects: 54
Study 18821287 — intervention group
Group type: COMPARATOR
Intervention: Sesame oil placebo
Number of subjects: 54
Study 16018757 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish
Number of subjects: 40
Study 16018757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser for 2 minutes
Number of subjects: 40
Study 16018757 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 5% sodium fluoride varnish and Nd:YAG laser
Number of subjects: 40
Study 16018757 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study 12593417 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc‐99m HMPAO brain SPECT in children with ADHD
Number of subjects: 20
Study 10519748 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic dental anesthesia
Number of subjects: 28
Study 10519748 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 28
Study 8540731 — intervention group
Group type: EXPERIMENTAL
Intervention: Hotyu‐ekki‐to
Number of subjects: 8
Study 8540731 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshi‐to
Number of subjects: 8
Study 8540731 — intervention group
Group type: EXPERIMENTAL
Intervention: Juzen‐taiho‐to
Number of subjects: 8
Study 8540731 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin (200 mg) alone
Number of subjects: 8
Study 1686184 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of riboflavin administered at night
Number of subjects: 20
Study 1686184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7334934 — intervention group
Group type: COMPARATOR
Intervention: 4 mg of oestriol succinate per day
Number of subjects: 70
Study 7334934 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of oestriol succinate per day
Number of subjects: 70
Study 7334934 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg of oestriol succinate per day (divided into two doses)
Number of subjects: 70
Study 31503258 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Coronary Revascularization (HCR)
Number of subjects: 155
Study 31503258 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 155
Study 31503258 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PTI)
Number of subjects: 155
Study 27918928 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐finishing grazing period
Number of subjects: 60
Study 27918928 — intervention group
Group type: COMPARATOR
Intervention: Concentrates without grazing
Number of subjects: 60
Study 27918928 — intervention group
Group type: EXPERIMENTAL
Intervention: Castration
Number of subjects: 60
Study 25040143 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (pre‐emptive) received 0.125% ropivacaine 6 mL 30 min before skin incision and every 60 min during surgery, then PCEA.
Number of subjects: 90
Study 25040143 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (routine) was given 0.125% ropivacaine 6 mL 30 min after surgery, then PCEA.
Number of subjects: 90
Study 25040143 — intervention group
Group type: COMPARATOR
Intervention: Group A (control) only received patient‐controlled epidural analgesia (PCEA).
Number of subjects: 90
Study 24105017 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 98
Study 21935685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dezocine 0.1 mg/kg
Number of subjects: 120
Study 21935685 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 120
Study 19703068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 49
Study 19703068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N-saline)
Number of subjects: 49
Study 17875948 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation, 1 g capsule for 14 days
Number of subjects: 26
Study 17875948 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g of corn oil)
Number of subjects: 26
Study 15136959 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up and counseling
Number of subjects: 34
Study 11477047 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention through in-practice meetings discussing referrals
Number of subjects: 0
Study 9134786 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily ratings of IBS symptoms for 8 weeks
Number of subjects: 25
Study 9134786 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with anxiety and depression
Number of subjects: 25
Study 8242939 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (double latex gloves)
Number of subjects: 71
Study 8242939 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (outer orthopaedic gloves over regular latex gloves)
Number of subjects: 71
Study 8242939 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (Repel gloves between two regular latex gloves)
Number of subjects: 71
Study 3295019 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral testosterone treatment (200 mg t.i.d.)
Number of subjects: 34
Study 3295019 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 34
Study 3295019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption
Number of subjects: 34
Study 30782866 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates
Number of subjects: 60
Study 30782866 — intervention group
Group type: COMPARATOR
Intervention: Aquatic aerobic exercises
Number of subjects: 60
Study 28503808 — intervention group
Group type: EXPERIMENTAL
Intervention: Extralevator abdominoperineal excision (ELAPE)
Number of subjects: 20
Study 28503808 — intervention group
Group type: COMPARATOR
Intervention: Conventional abdominoperineal excision (CAPE)
Number of subjects: 20
Study 26194884 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFSH plus rhLH from stimulation day 1 (group A)
Number of subjects: 202
Study 26194884 — intervention group
Group type: COMPARATOR
Intervention: rhFSH alone (days 1‐5) followed by rhFSH plus rhLH from day 6 (group B)
Number of subjects: 202
Study 23307631 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Robert Jones bandage (MRJB) applied for 24 hours (Group 1)
Number of subjects: 60
Study 23307631 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing (Group 2)
Number of subjects: 60
Study 21593009 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' suggested strategies for falls prevention (n = 629)
Number of subjects: 333
Study 21593009 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise as a falls prevention strategy
Number of subjects: 333
Study 21593009 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptualization of falls prevention
Number of subjects: 333
Study 17433577 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic formula (0.4 g/100 ml prebiotic galacto- and long-chain fructooligosaccharides)
Number of subjects: 0
Study 17433577 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (without added prebiotics)
Number of subjects: 0
Study 17433577 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic formula
Number of subjects: 0
Study 16965688 — intervention group
Group type: EXPERIMENTAL
Intervention: DLF regimen (n=48): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) and 48-hour infusion of 5-FU 3,000 mg/m(2) every 3 weeks, combined with cisplatin 80 mg/m(2)
Number of subjects: 98
Study 16965688 — intervention group
Group type: EXPERIMENTAL
Intervention: CLF regimen (n=32): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) and 48-hour infusion of 5-FU 3,000 mg/m(2) every 3 weeks, combined with carboplatin AUC=5
Number of subjects: 98
Study 16965688 — intervention group
Group type: EXPERIMENTAL
Intervention: DFM regimen (n=18): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) on day 1-5 plus pingyangmycin 5 mg/m(2) on day 1, 3, 5
Number of subjects: 98
Study 16965688 — intervention group
Group type: COMPARATOR
Intervention: Overall (all regimens)
Number of subjects: 98
Study 12934407 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia (Group A, n = 14)
Number of subjects: 42
Study 12934407 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based total intravenous anesthesia (Group B, n = 14)
Number of subjects: 42
Study 12934407 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-based inhalational-intravenous general anesthesia (Group C, n = 14)
Number of subjects: 42
Study 10210912 — intervention group
Group type: EXPERIMENTAL
Intervention: nicergoline 30 mg b.i.d.
Number of subjects: 72
Study 10210912 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study 8726094 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐adrenergic blocking agents
Number of subjects: 100
Study 8726094 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 100
Study 8726094 — intervention group
Group type: COMPARATOR
Intervention: Patients not on beta‐blockers
Number of subjects: 100
Study 8726094 — intervention group
Group type: COMPARATOR
Intervention: Patients on beta‐blockers
Number of subjects: 100
Study 1834010 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (6 mg/kg once daily)
Number of subjects: 0
Study 1834010 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (30 mg/kg once daily)
Number of subjects: 0
Study 1834010 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study 1834010 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin and vancomycin in serum ultrafiltrate and SMHB at 60 micrograms/ml
Number of subjects: 0
Study 6309918 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 30
Study 6309918 — intervention group
Group type: COMPARATOR
Intervention: ACTH4-9 analog
Number of subjects: 30
Study 6309918 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 30670099 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Group Psychoanalytic Psychotherapy (20 weeks, weekly sessions)
Number of subjects: 80
Study 30670099 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 80
Study 31255127 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection task with binaural streaming using frequency-proximity
Number of subjects: 19
Study 31255127 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding interaural delay or timbre-difference
Number of subjects: 19
Study 28881431 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartXide Fractional CO2 laser treatment
Number of subjects: 122
Study 26179246 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg daily for 5 days every 4 weeks
Number of subjects: 99
Study 26179246 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg/day
Number of subjects: 99
Study 26179246 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg 3 times a week
Number of subjects: 99
Study 26179246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 24080932 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversible interocclusal splint therapy (RIST)
Number of subjects: 80
Study 24080932 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care only
Number of subjects: 80
Study 24080932 — intervention group
Group type: EXPERIMENTAL
Intervention: Activator Method Chiropractic Technique (AMCT)
Number of subjects: 80
Study 24080932 — intervention group
Group type: COMPARATOR
Intervention: Sham AMCT
Number of subjects: 80
Study 21674396 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted body-weight-supported treadmill training (R-T)
Number of subjects: 13
Study 21674396 — intervention group
Group type: COMPARATOR
Intervention: Unassisted body-weight-supported treadmill training (T-R)
Number of subjects: 13
Study 21674396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of body-weight-supported treadmill training (R-T and T-R)
Number of subjects: 13
Study 19366448 — intervention group
Group type: EXPERIMENTAL
Intervention: AS-SMP three-day regimen (once daily for 3 days) (N = 476)
Number of subjects: 1384
Study 19366448 — intervention group
Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen (0 h, 12 h, 24 h) (N = 458)
Number of subjects: 1384
Study 19366448 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) regular 6 doses regimen (N = 450)
Number of subjects: 1384
Study 19366448 — intervention group
Group type: EXPERIMENTAL
Intervention: AS-SMP three-day regimen (once daily for 3 days)
Number of subjects: 1384
Study 19366448 — intervention group
Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen (0 h, 12 h, 24 h)
Number of subjects: 1384
Study 19366448 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) regular 6 doses regimen
Number of subjects: 1384
Study 19366448 — intervention group
Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen
Number of subjects: 1384
Study 16697153 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg/day
Number of subjects: 392
Study 16697153 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/day
Number of subjects: 392
Study 16697153 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 392
Study 16697153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 15265788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-dose therapy (2 courses of melphalan at 100 mg/m(2) with stem cell support)
Number of subjects: 194
Study 15265788 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy (6 courses of oral melphalan and prednisone)
Number of subjects: 194
Study 11297574 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-I treatment (15 microg/kg twice daily)
Number of subjects: 16